210
E. Flöistrup et al. / Tetrahedron Letters 52 (2011) 209–211
Table 1
with hindered Halophenols is greatly improved when the co-
reagent CuO is used. Comparing the two Methods A and B also sug-
gests the use of tetrakis(triphenylphosphine)palladium(0) rather
than ‘ligandless’ conditions for Stille cross-coupling reactions of
hindered biaryls. We think that these results will help in selecting
conditions for the preparation of biologically active and selective
estradiol mimetics.
Palladium-catalyzed cross-coupling of 2-trimethylstannyl-6-methoxybenzo[b]thio-
phene with arylhalides.a
R3
R3
R2
R2
R1
X
Pd(0)
R1
SnMe3
+
S
S
MeO
MeO
Me
Me
Entry
R1
R2
R3
X
Yielda (%)
Acknowledgments
1
2
3
4
H
H
OH
OH
H
H
H
Me
H
Br
Br
Br
I
98
Me
Me
H
61 (0)
37 (0)
46
The authors acknowledge the Swedish Research Council and the
Foundation for Knowledge and Competence Development (the KK-
foundation) for the financial support.
a
Yields refer to isolated yields. Reactions were heated at 95-100 °C over night.
Method A was used and conducted as described in reference 14. Yield in brackets
refers to runs without CuO.
Supplementary data
Supplementary data (experimental procedures and data for new
compounds) associated with this article can be found, in the online
Table 2
Palladium-catalyzed cross-coupling of arylstannanes with arylbromides
R2
Me
Me
R2
Br
References and notes
"Pd"
+
R1
Me3Sn
Me
1. Raloxifen displays estrogen agonist-like actions on bone tissues and serum
lipids while displaying potent estrogen antagonist properties in the breast and
uterus. See for example: Dodge, J. A.; Lugar, C. W.; Cho, S.; Short, L. L.; Sato, M.;
Yang, N. N.; Spangle, L. A.; Martin, M. J.; Phillips, D. L.; Glasebrook, A. L.;
Osborne, J. J.; Frolik, C. A.; Bryant, H. U. J. Steroid Biochem. Mol. Biol. 1997, 61,
97–106.
R1
Me
Entry
R1
R2
Methoda
Reaction timeb (h)
Yieldc (%)
1
2
3
4
5
OH
OBn
OH
OBn
OH
CHO
CHO
CHO
CHO
COOH
A
A
B
B
A
20 (102)
18 (23)
69 (30)
96 (50)
28 (20)
94, 80d (51)
47 (45)
25 (5)
2. Korach, K. S.; Chae, K.; McLachlan, J.; McKinney, J. D. Mol. Pharmacol. 1988, 61,
120–126.
8 (9)
3. Lesuisse, D.; Albert, E.; Bouchoux, F.; Cerede, E.; Lefrancois, J.-M.; Levif, M.-O.;
Tessier, S.; Tric, B.; Teutsch, G. Bioorg. Med. Chem. Lett. 2001, 11, 1709–1712.
4. (a) Malm, J.; Björk, P.; Gronowitz, S.; Hörnfeldt, A.-B. Tetrahedron Lett. 1992, 33,
2199–2202; (b) Gronowitz, S.; Björk, P.; Malm, J.; Hörnfeldt, A.-B. J. Organomet.
Chem. 1993, 460, 127–129; (c) Malm, J.; Björk, P.; Gronowitz, S.; Hörnfeldt, A.-B.
Tetrahedron Lett. 1994, 35, 3195–3196; (d) Björk, P.; Malm, J.; Hörnfeldt, A.-B.;
Gronowitz, S. Heterocycles 1997, 44, 237–253.
No yield
a
Methods A and B were as described in Refs. 14 and 17, with and without CuO
present.
b
Reaction times were monitored by TLC and determined as the time required for
all the starting material to be consumed. Reaction times in brackets refer to runs
without CuO.
5. Guitierrez, A. J.; Terhost, T. J.; Matteucci, M. D.; Froehler, B. C. J. Am. Chem. Soc.
1994, 116, 5540–5544.
c
Yields were estimated by HPLC analysis of the crude products as described in
6. McCullough, R. D.; Ewbank, P. C.; Loewe, R. S. J. Am. Chem. Soc. 1997, 119, 633–
634.
Ref. 14. Yields in brackets refer to runs without CuO.
d
Isolated yield in a separate synthesis.
7. Liu, C.-M.; Chen, B.-H.; Liu, W.-Y.; Wu, X.-L.; Ma, Y.-X. J. Organomet. Chem. 2000,
598, 348–352.
8. Clapham, B.; Sutherland, A. J. J. Org. Chem. 2001, 66, 9033–9037.
9. Mei, X.; Martin, R. H.; Wolf, C. J. Org. Chem. 2006, 71, 2854–2861.
10. Larhed, M.; Hoshino, M.; Hadida, S.; Curran, D. P.; Hallberg, A. J. Org. Chem.
1997, 62, 5583–5587.
11. Reviews: (a) Suzuki, A. J. Organomet. Chem. 1999, 576, 147; (b) Stanforth, S. P.
Tetrahedron 1998, 54, 263–303.
12. Applications employing highly active Suzuki catalysts: (a) Yin, J.; Matthew, M.
P.; Zhang, X.-X.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 1162–1163; (b)
Dupuis, C.; Adiey, K.; Charruault, L.; Michelet, V.; Savignac, M.; Genet, J.-P.
Tetrahedron Lett. 2001, 42, 6523–6526.
Method A was applied to the synthesis of hindered analogs of 2-
phenyl-6-methoxybenzo[b]thiophene (Table 1). Strikingly, the
presence of CuO was mandatory in order to obtain the desired
product (entries 2 and 3). Yields were lower when the R1-position
was substituted with a hydroxy group. Boronic acids were also
evaluated as coupling partners using a wide variety of conditions,
but resulted in complex reaction mixtures and low yields of the de-
sired products.
13. Renaud, P.; Lacôte, E.; Quaranta, L. Tetrahedron Lett. 1998, 39, 2123–2126.
14. Method A: A stirred mixture of the appropriate bromophenol (2.0 mmol), with
or without CuO (2.0 mmol), tetrakis(triphenylphosphine)palladium(0)
(0.1 mmol), and DMF (9.0 mL) was purged with argon for 15 min after which
the appropriate stannane (2.5 mmol) in DMF (1.0 mL) was added via a syringe
to the mixture. The reaction mixture was stirred at 95–100 °C until the starting
materials were consumed. The reaction mixture was filtered through a short
pad of Celite (1 cm) on silica (1 cm) in a glass filter funnel that was then
washed with ethyl acetate. The filtrate was washed with water, dried over
MgSO4, and concentrated in vacuo. The benzothiophene isolated products
(Table 1) were purified on a chromatotron (silica, 99:1, petroleum ether/ethyl
acetate). The isolated product from Table 2, entry 1 was purified by flash
chromatography (silica, 19:1, toluene/acetonitrile). Other products in Table 2
The cross-coupling of arylstannanes with aryl bromides was
evaluated by HPLC analysis of the reaction mixtures and the results
from these biaryl couplings are shown in Table 2. The presence of
the R2-formyl group represents the synthetic precursor of the
hydroxymethyl group shown in the estradiol mimetic (Fig. 1).
When Method A was applied for the palladium-catalyzed cross-
coupling, it was generally more effective with CuO than without
CuO (Tables 1 and 2). Addition of CuO in Method A resulted in
higher yields as well as a substantially shorter reaction time in
the reaction with the unprotected phenol (Table 2, entry 1), and
with the benzothiophenes there was no detectable product without
CuO. When a protected phenol (–OBn) was used as the coupling
partner, CuO-addition only resulted in a slight improvement
(Table 2, entry 2). Ligandless conditions (Method B) gave quite inef-
ficient cross-coupling of these substances, for both unprotected and
protected phenols (Table 2, entries 3 and 4), both with and without
CuO. Attempts to cross-couple the benzoic acid stannane only
resulted in a complex reaction mixture.
were isolated from
a part of the crude product of entries 1 and 2, for
characterization and to obtain HPLC reference material for co-injection.
Reversed Phase (RP) HPLC analyses of crude product mixtures (Table 2) were
carried out with a gradient of 75–100% of solvent B in Solvent A over 18 min
after an initial 0.1 min isocratic part with 75%
B (Reprosil RP-18 5 mm,
4.6 ꢀ 250 mm, mL/min; solvent A: 30% H2O in methanol, B: 25% isopropanol in
methanol). The response areas in the HPLC analysis (UV 260 nm) of the desired
biaryl peak in the crude product and in the crude product spiked with a known
amount of isolated biaryl compound were determined and the amount of
biaryl compound in the crude product was determined from the difference
between the spiked and non-spiked samples.
In summary, we have shown that the Stille palladium-catalyzed
cross-coupling of benzo[b]thiophene and benzaldehyde stannanes
15. Beletskaya, I. P. J. Organomet. Chem. 1983, 250, 551–564.
16. Farina, V.; Krishnan, B. J. Am. Chem. Soc. 1991, 113, 9585–9595.